Listen Now
Topics Covered
- Updates on the Treatment of Metastatic Triple Negative Breast Cancer, in the Context of COVID-19
- Novel Treatment Therapies
- Clinical Trial Updates
- How Research Offers Additional Treatment Options
- Biomarkers, Diagnostic Testing & Genomics: Why They Are So Important
- The Role of Precision Medicine in Improving Treatment Decisions
- Sequencing of Treatments
- Tips to Prevent & Manage Side Effects, Symptoms, Discomfort & Pain
- Guidelines to Prepare for Telehealth/Telemedicine Appointments to Reduce Your Exposure to COVID-19
- Key Questions to Ask Your Health Care Team, including Lifestyle & Quality-of-Life Concerns
- Practical Strategies to Cope with Metastatic Triple Negative Breast Cancer
- How to Find the Financial, Emotional & Social Supports to Cope
- Questions for Our Panel of Experts
Our Panel of Experts

Generosa Grana, MD, FACP
Medical Director, MD Anderson Cancer Center at Cooper, Division Head, Hematology & Medical Oncology, The Cooper Health System, Professor of Medicine, Cooper Medical School at Rowan University

Filipa Lynce, MD
Breast Medical Oncologist, Dana-Farber Cancer Institute, Harvard Medical School

Roberto A. Leon-Ferre, MD
Assistant Professor of Oncology, Consultant, Division of Medical Oncology, Mayo Clinic

Hayley Dinerman, JD
Co-Founder and Executive Director Triple Negative Breast Cancer Foundation®

Sam Fortune, MSW
Oncology Social Worker, CancerCare
Brochure
You can download the brochure for this workshop
Workshop Date
This workshop was originally recorded on October 06, 2021.